These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11361376)

  • 1. Lack of association between anti-V3 loop antibodies and perinatal transmission of HIV-1 in Kampala, Uganda.
    Epstein H; Guay L; Hom D; Mmiro F; Ndugwa C; Marum L; Olness K; Piwowar E; Kataaha P; Baenziger J
    Pediatr AIDS HIV Infect; 1994 Dec; 5(6):350-6. PubMed ID: 11361376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of maternal cytophilic human immunodeficiency virus (HIV)-1 V3 loop peptide-specific antibodies in infants with vertical HIV transmission.
    Wang XP; Oyaizu N; Pahwa S
    Pediatr Res; 1995 Sep; 38(3):384-9. PubMed ID: 7494664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1.
    Ugen KE; Goedert JJ; Boyer J; Refaeli Y; Frank I; Williams WV; Willoughby A; Landesman S; Mendez H; Rubinstein A
    J Clin Invest; 1992 Jun; 89(6):1923-30. PubMed ID: 1601999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mother to child transmission of HIV-1 in a Thai population: role of virus characteristics and maternal humoral immune response.
    Kittinunvorakoon C; Morris MK; Neeyapun K; Jetsawang B; Buehring GC; Hanson CV
    J Med Virol; 2009 May; 81(5):768-78. PubMed ID: 19319941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactions of Ugandan antisera with peptides encoded by V3 loop epitopes of human immunodeficiency virus type 1.
    Smith JD; Bruce CB; Featherstone AS; Downing RG; Biryahawaho B; Clegg JC; Carswell JW; Oram JD
    AIDS Res Hum Retroviruses; 1994 May; 10(5):577-83. PubMed ID: 7522494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different immune response of mice immunized with conjugates containing multiple copies of either consensus or mixotope versions of the V3 loop peptide from human immunodeficiency virus type 1.
    Cruz LJ; Iglesias E; Aguilar JC; Cabrales A; Reyes O; Andreu D
    Bioconjug Chem; 2004; 15(5):1110-7. PubMed ID: 15366967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretory anti-human immunodeficiency virus (HIV) antibodies in colostrum and breast milk are not a major determinant of the protection of early postnatal transmission of HIV.
    Becquart P; Hocini H; Lévy M; Sépou A; Kazatchkine MD; Bélec L
    J Infect Dis; 2000 Feb; 181(2):532-9. PubMed ID: 10669336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal antibodies to HIV-1 envelope domains: No correlation with HIV-1 vertical transmission in patients from Argentina.
    Calarota SA; Libonatti OV
    Scand J Immunol; 2000 Sep; 52(3):292-7. PubMed ID: 10972906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission. The NYC Perinatal HIV Transmission Collaborative Study.
    Parekh BS; Shaffer N; Pau CP; Abrams E; Thomas P; Pollack H; Bamji M; Kaul A; Schochetman G; Rogers M
    AIDS; 1991 Oct; 5(10):1179-84. PubMed ID: 1786145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
    Chakraborty K; Durani V; Miranda ER; Citron M; Liang X; Schleif W; Joyce JG; Varadarajan R
    Biochem J; 2006 Nov; 399(3):483-91. PubMed ID: 16827663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal antibodies to gp120 V3 sequence do not correlate with protection against vertical transmission of human immunodeficiency virus.
    Robertson CA; Mok JY; Froebel KS; Simmonds P; Burns SM; Marsden HS; Graham S
    J Infect Dis; 1992 Oct; 166(4):704-9. PubMed ID: 1527406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternofetal transmission of human immunodeficiency virus-1: the role of antibodies to the V3 primary neutralizing domain.
    Rubinstein A; Goldstein H; Calvelli T; Devash Y; Rubinstein R; Soeiro R; Lyman W
    Pediatr Res; 1993 Jan; 33(1 Suppl):S76-8; discussion S78-9. PubMed ID: 8433879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the intermolecular forces involved in the antibody-antigen interactions, using V3 synthetic peptides and sera from HIV1 seropositive patients.
    Măgureanu CG; Diaconu C; Alexandrescu R; Tirdei G; Cernescu C
    Rev Roum Virol; 1994; 45(3-4):143-57. PubMed ID: 7619736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vertical Transmission of HIV-1. Correlation with maternal viral load and plasma levels of CD4 binding site anti-gp120 antibodies.
    Khouri YF; McIntosh K; Cavacini L; Posner M; Pagano M; Tuomala R; Marasco WA
    J Clin Invest; 1995 Feb; 95(2):732-7. PubMed ID: 7860754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced fit in HIV-neutralizing antibody complexes: evidence for alternative conformations of the gp120 V3 loop and the molecular basis for broad neutralization.
    Rosen O; Chill J; Sharon M; Kessler N; Mester B; Zolla-Pazner S; Anglister J
    Biochemistry; 2005 May; 44(19):7250-8. PubMed ID: 15882063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perinatal transmission of HIV type 1: associations with maternal anti-HIV serological reactivity. Mothers and Infants Cohort Study and the HIV-1 Perinatal Serology Working Group.
    Goedert JJ; Dublin S
    AIDS Res Hum Retroviruses; 1994 Sep; 10(9):1125-34. PubMed ID: 7530026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of association between maternal antibodies to V3 loop peptides and maternal-infant HIV-1 transmission.
    Halsey NA; Markham R; Wahren B; Boulos R; Rossi P; Wigzell H
    J Acquir Immune Defic Syndr (1988); 1992; 5(2):153-7. PubMed ID: 1732507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission.
    Permar SR; Fong Y; Vandergrift N; Fouda GG; Gilbert P; Parks R; Jaeger FH; Pollara J; Martelli A; Liebl BE; Lloyd K; Yates NL; Overman RG; Shen X; Whitaker K; Chen H; Pritchett J; Solomon E; Friberg E; Marshall DJ; Whitesides JF; Gurley TC; Von Holle T; Martinez DR; Cai F; Kumar A; Xia SM; Lu X; Louzao R; Wilkes S; Datta S; Sarzotti-Kelsoe M; Liao HX; Ferrari G; Alam SM; Montefiori DC; Denny TN; Moody MA; Tomaras GD; Gao F; Haynes BF
    J Clin Invest; 2015 Jul; 125(7):2702-6. PubMed ID: 26053661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal HIV-1 RNA serum levels at delivery and vertical transmission in Uganda.
    Jackson JB; Hom D; Piwowar E; Ndugwa C; Kataaha P; Marum L; Guay L; Parsons J; Olness K; Mmiro F
    Pediatr AIDS HIV Infect; 1996 Feb; 7(1):37-42. PubMed ID: 11361471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta 2-microglobulin, HIV-1 p24 antibody and acid-dissociated HIV-1 p24 antigen levels: predictive markers for vertical transmission of HIV-1 in pregnant Ugandan women.
    Jackson JB; Kataaha P; Hom DL; Mmiro F; Guay L; Ndugwa C; Marum L; Piwowar E; Brewer K; Toedter G
    AIDS; 1993 Nov; 7(11):1475-9. PubMed ID: 8280414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.